[go: up one dir, main page]

AU2003263895A1 - Contraceptive methods and formulations - Google Patents

Contraceptive methods and formulations

Info

Publication number
AU2003263895A1
AU2003263895A1 AU2003263895A AU2003263895A AU2003263895A1 AU 2003263895 A1 AU2003263895 A1 AU 2003263895A1 AU 2003263895 A AU2003263895 A AU 2003263895A AU 2003263895 A AU2003263895 A AU 2003263895A AU 2003263895 A1 AU2003263895 A1 AU 2003263895A1
Authority
AU
Australia
Prior art keywords
formulations
contraceptive methods
contraceptive
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263895A
Other versions
AU2003263895A8 (en
Inventor
Craig R. Travis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immugen Pharmaceuticals Inc
Original Assignee
Immugen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immugen Pharmaceuticals Inc filed Critical Immugen Pharmaceuticals Inc
Publication of AU2003263895A1 publication Critical patent/AU2003263895A1/en
Publication of AU2003263895A8 publication Critical patent/AU2003263895A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003263895A 2002-08-16 2003-08-15 Contraceptive methods and formulations Abandoned AU2003263895A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40404002P 2002-08-16 2002-08-16
US60/404,040 2002-08-16
PCT/US2003/025826 WO2004016254A2 (en) 2002-08-16 2003-08-15 Contraceptive methods and formulations

Publications (2)

Publication Number Publication Date
AU2003263895A1 true AU2003263895A1 (en) 2004-03-03
AU2003263895A8 AU2003263895A8 (en) 2004-03-03

Family

ID=31888313

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263895A Abandoned AU2003263895A1 (en) 2002-08-16 2003-08-15 Contraceptive methods and formulations

Country Status (2)

Country Link
AU (1) AU2003263895A1 (en)
WO (1) WO2004016254A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033527B2 (en) 2018-02-07 2021-06-15 Immugen Pharma Llc Non-hormonal treatment of the genitourinary syndrome of menopause

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000830A1 (en) * 2003-06-24 2005-01-06 Gw Pharma Limited Pharmaceutical compositions comprising cabbinochreme type compounds
EP2961402B1 (en) 2013-02-28 2024-10-02 Teewinot Technologies Limited Biosynthesis of cannabinoids
CA2959283A1 (en) 2014-08-25 2016-03-03 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of cannabinoid compounds
US20230059087A1 (en) * 2020-01-08 2023-02-23 Chengdu Baiyu Pharmaceutical Co., Ltd. Cannabidiol derivatives, preparation method thereof and use thereof
WO2021139739A1 (en) * 2020-01-08 2021-07-15 成都百裕制药股份有限公司 Cannabidiol derivative, and preparation method therefor and medical use thereof
CN113087743B (en) 2020-01-08 2023-04-28 成都百裕制药股份有限公司 Tetrahydrocannabinol derivative, preparation method thereof and medical application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053615A (en) * 1900-01-01
IL26902A (en) * 1965-12-07 1970-06-17 Commercial Solvents Corp Preparation for inhibiting spermiogenesis containing 6-(10'-hydroxy-undecyl)-2,4-dihydroxy-benzoic acid lactone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033527B2 (en) 2018-02-07 2021-06-15 Immugen Pharma Llc Non-hormonal treatment of the genitourinary syndrome of menopause

Also Published As

Publication number Publication date
WO2004016254A2 (en) 2004-02-26
AU2003263895A8 (en) 2004-03-03
WO2004016254A3 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AU2002337953A1 (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003241477A1 (en) Nanoparticulate polycosanol formulations and novel polycosanol combinations
AUPR510001A0 (en) Formulation and method
AU2003287443A1 (en) Compositions and methods for pain reduction
AU2003279911A1 (en) Therapeutic formulations
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2003271183A1 (en) Block copolymer and application thereof
AU2003213120A1 (en) Human rnase iii and compositions and uses thereof
EP1370240A4 (en) Neuroprotectants formulations and methods
AU2003217309A1 (en) Novel pyranosyl cytosines: pharmaceutical formulations and methods
AU2003263895A1 (en) Contraceptive methods and formulations
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2003245524A1 (en) Cryosurgery compositions and methods
AUPR472701A0 (en) Condom
AU2002359869A1 (en) Pak5-related compositions and methods
AU2003224331A1 (en) Insecticides and arachnicides
AU2003216442A1 (en) Enkurin and uses thereof
AU2003255232A1 (en) Antigiardial agents and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase